- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 25, 2025 | 72.82M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $80M |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $60M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $39.87M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $38.28M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $435.62M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $633.81M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $895.59M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $1.08B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $593.24M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $632.02M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $2.93B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $2.92B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $1.84B |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $1.78B |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 73.03M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 73.01M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $20M |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $115.79M |
| Capex | Q3 2025 · Mar 31, 2024 | $34.35M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $336.24M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $1.19 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $3.85 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $1.20 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $3.85 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $62.25M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $211.3M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $35.99M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $108.36M |
| Net Income | Q3 2025 · Mar 31, 2024 | $87.1M |
| Net Income | Q3 2025 · Mar 31, 2024 | $280.74M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $112.1M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $363.77M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $328.22M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $972.21M |
| Revenue | Q3 2025 · Mar 31, 2024 | $538.56M |
| Revenue | Q3 2025 · Mar 31, 2024 | $1.66B |